SCHEMBL31321997

SCHEMBL31321997

COc1cc2c(C)n[nH]c(=O)c2cc1OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 3/20 0.54
CTSV O60911 2/20 0.54
KDM1A O60341 1/20 0.50
ELANE P08246 1/20 0.48
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
TSHR P16473 1/20 0.47
CYP2C19 P33261 1/20 0.47
SRD5A1 P18405 1/20 0.46
SRD5A2 P31213 1/20 0.46
PDE4A P27815 3/20 0.45
PDE4B Q07343 3/20 0.45
PDE4C Q08493 3/20 0.45
PDE4D Q08499 3/20 0.45
PDE3B Q13370 1/20 0.44
PDE3A Q14432 1/20 0.44
ALDH1A1 P00352 2/20 0.44
MAPT P10636 2/20 0.44
HSD17B10 Q99714 1/20 0.44
KDM4C Q9H3R0 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11546262 0.82 PDE4A (0.49) CYP3A4CYP2C9TSHRCYP2C19PDE4A
SCHEMBL29945777 0.80 IP6K1 (0.54) CTSLCTSVNPC1RAB9AL3MBTL1
SCHEMBL23526181 0.80 IP6K1 (0.54) CTSLCTSVNPC1RAB9AL3MBTL1
SCHEMBL25548688 0.78 CYP2C9 (0.70) CYP3A4CYP2C9TSHRCYP2C19PDE4A
SCHEMBL7255463 0.76 CTSV (0.68) CTSLCTSVELANESRD5A1SRD5A2
SCHEMBL1943022 0.76 CTSV (0.68) CTSLCTSVELANESRD5A1SRD5A2
SCHEMBL27041281 0.76 ELANE (0.58) CTSLCTSVKDM1AELANETSHR
SCHEMBL20509552 0.76 ELANE (0.58) CTSLCTSVKDM1AELANETSHR
SCHEMBL13239968 0.75 CYP3A4 (0.80) CYP3A4CYP2C9TSHRCYP2C19PDE4A
SCHEMBL1013586 0.75 IP6K1 (0.62) CTSLCTSVKDM1AELANEPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250059182-A1 SOS1 INHIBITORS MIRATI THERAPEUTICS, INC 2025-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250059182-A1 SOS1 INHIBITORS SOS1, SOS2, SOST CTSL 3532/4885CTSV 3131/4885KDM1A 1927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.